Your browser doesn't support javascript.
loading
Cancer risk-reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast).
Carneiro, Vandré Cabral Gomes; Gifoni, Ana Carolina Leite Vieira Costa; Mauro Rossi, Benedito; Andrade, Carlos Eduardo Mattos da Cunha; Lima, Fernanda Teresa de; Galvão, Henrique de Campos Reis; Casali da Rocha, Jose Claudio; Silva Barreto, Leonardo Silveira da; Ashton-Prolla, Patrícia; Guindalini, Rodrigo Santa Cruz; Farias, Terence Pires de; Andrade, Wesley Pereira; Fernandes, Paulo Henrique de Sousa; Ribeiro, Reitan; Lopes, Andre; Tsunoda, Audrey Tieko; Azevedo, Bruno Roberto Braga; Marins, Carlos Augusto Martinez; Oliveira Uchôa, Diego Nunes de Albuquerque; Dos Santos, Evandro Airton Sordi; Fernández Coimbra, Felipe José; Dias Filho, Francisco Alcides; Lopes, Francisco Carlos de Oliveira; Fernandes, Francisco Guilherme; Ritt, Guilherme Fonteles; Laporte, Gustavo Andreazza; Guimaraes, Gustavo Cardoso; Feitosa E Castro Neto, Heládio; Dos Santos, Jocela Cristina; de Carvalho Vilela, Jordana Botelho; Meinhardt Junior, Jorge Guardiola; Cunha, Juliano Rodrigues da; Medeiros Milhomem, Leonardo; da Silva, Luciana Mata; Maciel, Luiza de Freitas; Ramalho, Nathalia Moreira; Leite Nunes, Rafael; Guido de Araújo, Rodrigo; de Assunção Ehrhardt, Rogério; Delgado Bocanegra, Ronald Enrique; Silva Junior, Tyrone Cesar; Oliveira, Viviane Rezende de; Silva Surimã, Walyson; de Melo Melquiades, Miriam; Ribeiro, Heber Salvador de Castro; Oliveira, Alexandre Ferreira.
Afiliación
  • Carneiro VCG; Department of Surgey, Gynecology, Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.
  • Gifoni ACLVC; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil.
  • Mauro Rossi B; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
  • Andrade CEMDC; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
  • Lima FT; Department of Oncogenetic, Surgical Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
  • Galvão HCR; Department of Oncogynecology, Barretos Cancer Hospital, Barretos, Brazil.
  • Casali da Rocha JC; Department of Oncogenetic, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Silva Barreto LSD; Department of Oncogenetic, UNIFESP-EPM, São Paulo, Brazil.
  • Ashton-Prolla P; Department of Oncogenetic, DASA, São Paulo, Brazil.
  • Guindalini RSC; Department of Oncogenetic, Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil.
  • Farias TP; Department of Surgery, HUOL/UFRN, Natal, Brazil.
  • Andrade WP; Department of Genetic, Hospital de Clínicas de Porto Alegre/UFRGS, Porto Alegre, Brazil.
  • Fernandes PHS; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
  • Ribeiro R; Department of Head and Neck, Oncological Surgery, INCA, Rio de Janeiro, Brazil.
  • Lopes A; Department of Surgery, Hospital Beneficência Portuguesa, São Paulo, Brazil.
  • Tsunoda AT; Department of Surgery, Hospital Oswaldo Cruz, São Paulo, Brazil.
  • Azevedo BRB; Department of Surgery, Hospital Santa Catarina, São Paulo, Brazil.
  • Marins CAM; Department of Surgery, Universidade Federal de Uberlândia, Uberlândia, Brazil.
  • Oliveira Uchôa DNA; Department of Surgical Oncology, Hospital Erasto Gaertner, Curitiba, Brazil.
  • Dos Santos EAS; Department of Surgical Oncology, São Camilo Oncologia, São Paulo, Brazil.
  • Fernández Coimbra FJ; Department of Surgical Oncology, Hospital Erasto Gaertner, Curitiba, Brazil.
  • Dias Filho FA; Department of Surgery, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
  • Lopes FCO; Department of Surgical Oncology, Oncoclínicas, Curitiba, Brazil.
  • Fernandes FG; Department of Surgery, Pilar Hospital, Curitiba, Brazil.
  • Ritt GF; Department of Head and Neck, Oncological Surgery, INCA, Rio de Janeiro, Brazil.
  • Laporte GA; Department of Surgery, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil.
  • Guimaraes GC; Department of Surgery, Hospital Universitário Professor Alberto Antunes-UFAL, Maceió, Brazil.
  • Feitosa E Castro Neto H; Department of Surgery, IMERV, Ribeirão Preto, Brazil.
  • Dos Santos JC; Department of Oncogenetic, Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil.
  • de Carvalho Vilela JB; Department of Surgery, Hospital Regional de Cacoal, Cacoal, Brazil.
  • Meinhardt Junior JG; Department of Surgery, Hospital do Coração de Londrina, Londrina, Brazil.
  • Cunha JRD; Department of Surgical Oncology, Hospital do Câncer-UOPECCAN, Cascavel, Brazil.
  • Medeiros Milhomem L; Department of Surgery, AMO/OSID, Salvador, Brazil.
  • da Silva LM; Department of Surgery, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
  • Maciel LF; Department of Surgery, Hospital Beneficência Portuguesa, São Paulo, Brazil.
  • Ramalho NM; Department of Surgical Oncology, Instituto do Câncer do Ceará, Fortaleza, Brazil.
  • Leite Nunes R; Department of Surgery, HUPAA/UFAL, Maceió, Brazil.
  • Guido de Araújo R; Department of Surgical oncology, Hospital do Câncer Araújo Jorge, Goiânia, Brazil.
  • de Assunção Ehrhardt R; Department of Surgery, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
  • Delgado Bocanegra RE; Department of Surgery, Hospital Santa Rita, Porto Alegre, Brazil.
  • Silva Junior TC; Department of Surgery, Universidade Federal de Uberlândia, Uberlândia, Brazil.
  • Oliveira VR; Department of Surgery, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Brazil.
  • Silva Surimã W; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil.
  • de Melo Melquiades M; Department of Head and Neck, Oncological Surgery, INCA, Rio de Janeiro, Brazil.
  • Ribeiro HSC; Department of Surgey, Gynecology, Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.
  • Oliveira AF; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
J Surg Oncol ; 126(1): 10-19, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35689574
ABSTRACT

BACKGROUND:

Risk-reducing operations are an important part of the management of hereditary predisposition to cancer. In selected cases, they can considerably reduce the morbidity and mortality associated with cancer in this population.

OBJECTIVES:

The Brazilian Society of Surgical Oncology (BSSO) developed this guideline to establish national benchmarks for cancer risk-reducing operations.

METHODS:

The guideline was prepared from May to December 2021 by a multidisciplinary team of experts to discuss the surgical management of cancer predisposition syndromes. Fourteen questions were defined and assigned to expert groups that reviewed the literature and drafted preliminary recommendations. Following a review by the coordinators and a second review by all participants, the groups made final adjustments, classified the level of evidence, and voted on the recommendations.

RESULTS:

For all questions including risk-reduction bilateral salpingo-oophorectomy, hysterectomy, and mastectomy, major agreement was achieved by the participants, always using accessible alternatives.

CONCLUSION:

This and its accompanying article represent the first guideline in cancer risk reduction surgery developed by the BSSO, and it should serve as an important reference for the management of families with cancer predisposition.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Oncología Quirúrgica / Ginecología Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: J Surg Oncol Año: 2022 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Oncología Quirúrgica / Ginecología Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: J Surg Oncol Año: 2022 Tipo del documento: Article País de afiliación: Brasil